Last reviewed · How we verify
NCT03591679
Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section
NA trial testing Oxytocin in Post Partum Hemorrhage in 1,070 participants. Completed in 1 January 2019.
30 November 2018
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 1,070 |
| Start date | 1 December 2017 |
| Primary completion | 30 November 2018 |
| Estimated completion | 1 January 2019 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Oxytocin (OXYTOCIN) — full drug profile →
- bilateral uterine artery ligation
Conditions studied
- Post Partum Hemorrhage — all drugs for Post Partum Hemorrhage →
Sponsor
Assiut University
Who can join
Eligibility, female only, with Post Partum Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The patients were recruited from women attending labor ward to undergo cesarean section.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Randomized controlled trial of the effect of bilateral uterine artery ligation during cesarean among women at risk of uterine atony.
Samy A, Ali MK, Abbas AM, Wahab HA, et al · · 2020 · PMID 31755559 · DOI 10.1002/ijgo.13064
Verify or expand the search:
- PubMed search for NCT03591679
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Oxytocin
Trials testing the same drug.
- NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
- NCT07188207 — Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section · NA · not yet recruiting
- NCT06968481 — Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage · Phase 2 · not yet recruiting
- NCT07265180 — Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison · NA · recruiting
- NCT07119398 — Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM · Phase 4 · recruiting
Other recruiting trials for Post Partum Hemorrhage
Currently open trials in the same condition.
- NCT05488457 — Oxytocin Pharmacokinetics and Pharmacodynamics · Phase 2 · recruiting
- NCT06604325 — Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery. · NA · recruiting
- NCT06577922 — Evaluation of Maternal & Newborn Health Simulation Lab Centers of Excellence in Nepal · NA · recruiting
- NCT05370820 — Prevention of Postpartum Hemorrhage With Tranexamic Acid · Phase 2 · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03591679 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 11 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03591679.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing